Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2018
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)Cindy Neuzillet, Sébastien Gaujoux, Nicolas Williet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 StudyAngela Lamarca, Maxime Ronot, Salma Moalla, et al.
Nature Communications|October 28, 2025
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasmsBenjamin Goeppert, Alphonse Charbel, Reka Toth, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2021
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their DiseaseClément Mennetrey, Maëlle Le Bras, Aurélie Bando-Delaunay, et al.
Nature Communications|June 13, 2023
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinomaCharlie Saillard, Flore Delecourt, Benoit Schmauch, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2024
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world studyJeannie M'Baloula, David Tougeron, Alice Boilève, et al.
Endocrine-Related Cancer|June 1, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETsLouis de Mestier, Angela Lamarca, Jorge Hernando, et al.
The American Journal of Gastroenterology|September 21, 2023
Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine TumorsLoïc Cheminel, Alexandru Lupu, Timothée Wallenhorst, et al.
Lancet (London, England)|July 2, 2026
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trialThomas Walter, Henning Jann, Catherine Ansquer, et al.
Journal of Neuroendocrinology|June 22, 2023
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECISTLouis de Mestier, Matthieu Resche-Rigon, Clarisse Dromain, et al.
Pageof 13